GP Surgeries in North Central London Launch Mobile Services

iPLATO HealthcarePatients of GP practices in North Central London including Enfield, Barnet, Haringey, Camden and Islington will soon start receiving appointment reminders and health information via text message. Already in use by a large number of practices in the area this service aims to improve patient access to GP services, reduce unnecessary visits to A&E as well as informing patients about important NHS services such as cancer screening and seasonal flu immunisation.

North Central London NHS Cluster has committed to fund participating surgeries across the Boroughs to use iPLATO Patient Care Messaging for the next three years. With 91% of the UK adult population owning a mobile phone (77% in the 65-74 age group) surgeries can reach a significant number of their patients through this service. Text messages are free to receive for the patient. If they have a smartphone such as iPhone, Blackberry or Android patients will also be able to access information about their local health services via their mobile phone.

Dr. Janet High GP at the Park Lodge Medical Centre, one of the current existing practice said, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

Patients who choose to respond to text reminders or access the smartphone service will be charged standard operator rates depending on their individual contract. Patients can opt out of the service at any time by contacting their surgery.

To benefit from these services patients are encouraged to hand in their mobile phone number to their practice. If patients have already their mobile phone number recorded with their GP they will receive a text message to let them know that the service is running as part of service launch.

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company dedicated to mobile health since 2006.

iPLATO's evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with healthcare professionals and provider organisations, support patients in achieving longer, healthier lives.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...